OTUD1 was initially characterized as a biomarker for thyroid carcinoma by a single-chain variable fragment antibody-reactive antigen, using two-dimensional polyacrylamide gel electrophoresis followed by mass spectrometry, although a detailed functional analysis of OTDU1 in thyroid cancer has not been performed [20]. The gene discussed is OTUD1; the disease is thyroid gland carcinoma.